METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP)
Sponsor study identifier
Secondary identifiers
interventional
340
1 country
1
Study Start
April 1996
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2000
Actual (reported)Study Completion
Not reported
Date not reportedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether surgery plus combination chemotherapy is more effective than surgery alone in treating patients with lung metastases from soft tissue sarcoma. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery plus combination chemotherapy with that of surgery alone in treating patients who have soft tissue sarcoma that has spread to the lung.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1996
Date type not reportedThis date has not been verified as actual or estimated.
November 1, 1999
Actual (reported)November 2000
Actual (reported)April 22, 2004
Actual (reported)Lund University Hospital
Lund, SE-22185, Sweden
A.N. Van Geel, MD
Daniel Den Hoed Cancer Center at Erasmus Medical Center
Ronald H. Blum, MD
NYU Langone Health
Thor A. Alvegard, MD, PhD
Lund University Hospital
Laurence H. Baker, DO, FACOI
University of Michigan Rogel Cancer Center
First Submitted
November 1, 1999
First Posted
April 22, 2004
Study Start
April 1996
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2000
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Last Updated
July 11, 2012
Record last verified: 2012-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: